870
Views
0
CrossRef citations to date
0
Altmetric
Research Article

New imidazole-2-thiones linked to acenaphythylenone as dual DNA intercalators and topoisomerase II inhibitors: structural optimization, docking, and apoptosis studies

, ORCID Icon, ORCID Icon, , , , , ORCID Icon & ORCID Icon show all
Article: 2311818 | Received 09 Aug 2023, Accepted 24 Jan 2024, Published online: 15 Mar 2024
 

Abstract

In this article, a new series of 2-((3,5-disubstituted-2-thioxo-imidazol-1-yl)imino)acenaphthylen-1(2H)-ones were synthesized. Imidazole-2-thione with acenaphthylen-one gave a hybrid scaffold that integrated key structural elements essential for DNA damage via direct DNA intercalation and inhibition of the topoisomerase II enzyme. All the synthesized compounds were screened to detect their DNA damage using a terbium fluorescent probe. Results demonstrated that 4-phenyl-imidazoles 5b and 5e in addition to 4-(4-chlorophenyl)imidazoles 5h and 5j would induce detectable potent damage in ctDNA. The four most potent compounds as DNA intercalators were further evaluated for their antiproliferative activity against HepG2, MCF-7 and HCT-116 utilizing the MTT assay. The highest anticancer activity was recorded with compounds 5b and 5h against the breast cancer cell line MCF-7 which were 1.5- and 3- folds more active than doxorubicin, respectively. Therefore, imidazole-2-thione tethered acenaphthylenone derivatives can be considered as promising scaffold for the development of effective dual DNA intercalators and topoisomerase II inhibitors.

Acknowledgements

The authors thank the Deanship of Scientific Research at Prince Sattam bin Abdulaziz University under research project No 2021/01/18104.

Author contributions

A. H. Mohamed: Concept, analysis, editing; M. B. Alshammari; A. Ahmad: editing; A. A. Aly: Concept, writing, editing and submit; K. U. Sadek: editing; E. A. Aziz: Methodology, A. F. Yazbi, E. J. El-Agroudy and M. E. Abdelaziz: concept, design, methodology ,analysis and writing. All authors agree to be accountable of all aspects of the work.

Disclosure statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.

Data availability statement

Data set generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

Additional information

Funding

Not applicable.